Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development…
iOS 12、watchOS 5、tvOS 12、macOS Mojave 版本更新日子確定 = 1140 ) { /* large monitors */ document.write(”); (adsbygoogle = window.adsbygoogle || []).push({}); …